$2.03 Billion is the total value of Redmile Group, LLC's 65 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 55.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARRY | Buy | ARRAY BIOPHARMA INC | $215,946,000 | +60.3% | 17,556,586 | +9.1% | 10.65% | +29.9% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $108,570,000 | +44.4% | 906,642 | +5.4% | 5.36% | +17.0% |
| SGEN | Buy | SEATTLE GENETICS INC | $100,318,000 | +191.5% | 1,843,733 | +177.2% | 4.95% | +136.2% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $82,121,000 | +14.7% | 996,610 | +30.4% | 4.05% | -7.0% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $79,340,000 | +211.6% | 6,476,766 | +191.2% | 3.91% | +152.5% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $76,105,000 | – | 2,246,300 | +100.0% | 3.75% | – |
| INSM | Buy | INSMED INC | $62,159,000 | +29220.3% | 1,991,646 | +15987.6% | 3.07% | +23484.6% |
| IMGN | Buy | IMMUNOGEN INC | $61,670,000 | +66.4% | 8,061,497 | +54.7% | 3.04% | +34.8% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $49,323,000 | +19.2% | 2,267,707 | +1.9% | 2.43% | -3.4% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $47,825,000 | +24.9% | 2,889,710 | +5.7% | 2.36% | +1.2% |
| LIVN | Buy | LIVANOVA PLC | $44,312,000 | +241.4% | 632,488 | +198.3% | 2.19% | +176.7% |
| CNC | Buy | CENTENE CORP DEL | $39,153,000 | +23.1% | 404,600 | +1.6% | 1.93% | -0.3% |
| ICUI | Buy | ICU MED INC | $37,495,000 | +64.0% | 201,750 | +52.3% | 1.85% | +33.0% |
| AET | New | AETNA INC NEW | $37,182,000 | – | 233,837 | +100.0% | 1.83% | – |
| EHTH | Buy | EHEALTH INC | $31,956,000 | +38.9% | 1,337,623 | +9.3% | 1.58% | +12.6% |
| PRAH | New | PRA HEALTH SCIENCES INC | $30,621,000 | – | 402,014 | +100.0% | 1.51% | – |
| ELGX | Buy | ENDOLOGIX INC | $29,189,000 | -5.7% | 6,544,676 | +2.8% | 1.44% | -23.6% |
| NITE | New | NIGHTSTAR THERAPEUTICS PLCadr | $28,839,000 | – | 1,769,346 | +100.0% | 1.42% | – |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $28,737,000 | +54.4% | 189,008 | +30.9% | 1.42% | +25.2% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $28,640,000 | +41.5% | 552,041 | +15.9% | 1.41% | +14.7% |
| XNCR | Buy | XENCOR INC | $27,511,000 | +9.7% | 1,200,294 | +1.1% | 1.36% | -11.1% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $25,157,000 | +18.5% | 723,330 | +1.4% | 1.24% | -4.0% |
| EPZM | New | EPIZYME INC | $23,051,000 | – | 1,210,000 | +100.0% | 1.14% | – |
| CMRX | Buy | CHIMERIX INC | $22,184,000 | -3.3% | 4,225,575 | +0.4% | 1.09% | -21.6% |
| DPLO | New | DIPLOMAT PHARMACY INC | $19,823,000 | – | 957,155 | +100.0% | 0.98% | – |
| NVTA | Buy | INVITAE CORP | $19,792,000 | +154.9% | 2,112,240 | +160.1% | 0.98% | +106.3% |
| GLYC | Buy | GLYCOMIMETICS INC | $16,985,000 | +153.8% | 1,214,088 | +102.5% | 0.84% | +105.9% |
| MEDP | Buy | MEDPACE HLDGS INC | $15,939,000 | +144.2% | 499,640 | +122.0% | 0.79% | +98.0% |
| AMED | Buy | AMEDISYS INC | $15,873,000 | +7422.7% | 283,648 | +8352.0% | 0.78% | +5923.1% |
| CBAY | New | CYMABAY THERAPEUTICS INC | $13,276,000 | – | 1,647,100 | +100.0% | 0.66% | – |
| NLNK | New | NEWLINK GENETICS CORP | $12,712,000 | – | 1,248,700 | +100.0% | 0.63% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $11,957,000 | – | 722,880 | +100.0% | 0.59% | – |
| LIFE | New | ATYR PHARMA INC | $9,528,000 | – | 1,886,792 | +100.0% | 0.47% | – |
| PRQR | Buy | PROQR THRAPEUTICS N V | $7,774,000 | -6.3% | 1,602,975 | +0.4% | 0.38% | -24.2% |
| TFX | New | TELEFLEX INC | $7,589,000 | – | 31,365 | +100.0% | 0.37% | – |
| PETQ | New | PETIQ INC | $6,682,000 | – | 246,743 | +100.0% | 0.33% | – |
| CTLT | Buy | CATALENT INC | $5,895,000 | +15.1% | 147,663 | +1.2% | 0.29% | -6.7% |
| OVID | Buy | OVID THERAPEUTICS INC | $3,771,000 | -11.0% | 451,182 | +0.5% | 0.19% | -27.9% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $2,606,000 | +1.6% | 100,960 | +6.8% | 0.13% | -17.3% |
| HOLX | New | HOLOGIC INC | $734,000 | – | 20,000 | +100.0% | 0.04% | – |
| LHCG | New | LHC GROUP INC | $235,000 | – | 3,310 | +100.0% | 0.01% | – |
| SHPG | New | SHIRE PLCsponsored adr | $208,000 | – | 1,360 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.